Last reviewed · How we verify
Pulmonary hypertension-specific therapy — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Pulmonary hypertension-specific therapy (Pulmonary hypertension-specific therapy) — Irina E. Chazova.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pulmonary hypertension-specific therapy TARGET | Pulmonary hypertension-specific therapy | Irina E. Chazova | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pulmonary hypertension-specific therapy CI watch — RSS
- Pulmonary hypertension-specific therapy CI watch — Atom
- Pulmonary hypertension-specific therapy CI watch — JSON
- Pulmonary hypertension-specific therapy alone — RSS
Cite this brief
Drug Landscape (2026). Pulmonary hypertension-specific therapy — Competitive Intelligence Brief. https://druglandscape.com/ci/pulmonary-hypertension-specific-therapy. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab